Newel Health announces that ROHKEA® VR Therapy has received MDR Class IIa certification as a medical device, paving the way for its European commercialization. This certification validates ROHKEA®’s intended use is to provide an automated intervention based on cognitive behavioral therapy to help patients overcome fear of movement caused by chronic musculoskeletal pain.
Home Ventures
With our help, individuals, teams, or large enterprises can identify opportunities, quantify their potential and create a roadmap to transform their vision into a reality with clear business objectives